skip to main content
Home
About Us
Leadership & Advisors
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investors
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Information Request
Contact Us
Go to...
Home
About Us
Leadership & Advisors
Contact Us
Products
Transplant
VitaGraft Liver
VitaGraft Kidney
Oncology
DetermaIO
DetermaCNI
Publications
Biopharma Services
Investor
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Management Team
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Contact Us
.
Home
>
Investors
>
News Releases
>
2025
iMDx Company Profile
Stock Information
Events & Presentations
SEC Filings
Analyst Coverage
News Releases
Quarterly Documents
Corporate Governance
Management Team
Board of Directors
Committees
Governance Documents
Board Diversity Matrix
Information Request
Contact Us
Email Alerts
Print
Share page
Email
Facebook
Twitter
News Releases
Register for email alerts
.
All Categories
All Categories
General
Earnings
Corporate News
Date Descending
Date Descending
Date Ascending
2025
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Date
Title
Document
Date
Feb 11, 2025
Title
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Document
PDF
Date
Feb 10, 2025
Title
Oncocyte Prices $29.1 Million Equity Offering
Document
PDF
Date
Jan 08, 2025
Title
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Document
PDF
Date
Jan 06, 2025
Title
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Document
PDF
<<
<
1
2
3
>
>>
